Increasing prevalence of nasal and rectal colonization with methicillin-resistant Staphylococcus aureus in children with cancer

Pediatric Blood and Cancer

Volumn 55, Issue 7, 2010, Pages 1317-1322

  Srinivasan, Ashok ^a,b   Seifried, Steven E ^c   Zhu, Liang ^a   Srivastava, Deo K ^a   Perkins, Rosalie ^a   Shenep, Jerry L ^a,b   Bankowski, Matthew J ^c,d   Hayden, Randall T ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c UNIVERSITY OF HAWAII   (United States)

^d Diagnostic Laboratory Services Inc   (United States)

Author keywords

Cancer; Children; Colonization; Methicillin resistant Staphylococcus aureus; Panton Valentine Leukocidin

Indexed keywords

CEFOXITIN; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; OXACILLIN; PANTON VALENTINE LEUKOCIDIN; PENICILLIN DERIVATIVE; PSEUDOMONIC ACID; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM ISOLATE; CANCER PATIENT; CHILD; CLINICAL ARTICLE; GENETIC SCREENING; GENOTYPE; HUMAN; INFECTION RISK; INOCULATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MOLECULAR EPIDEMIOLOGY; NOSE CAVITY; NOSE SMEAR; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RECTUM; RECURRENT INFECTION; RETROSPECTIVE STUDY;

BACTERIAL TOXINS; CHILD; EXOTOXINS; FEMALE; HUMANS; LEUKOCIDINS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; NEOPLASMS; NOSE; RECTUM; STAPHYLOCOCCAL INFECTIONS;

EID: 78049302712     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22815     Document Type: Article

References (38)

1. Herold BC, Immergluck LC, Maranan MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 1998; 279: 593-598.
2. Daum RS, Ito T, Hiramatsu K. et al. A novel methicillin-resistant cassette in community-acquired methicillin-resistant Staphylococcus aureus isolates of diverse genetic backgrounds. J Infect Dis 2002; 186: 1344-1347.
3. Lina G, Piemont Y, Godail-Gamot F. et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999; 29: 1128-1132.
4. Tenover FC, McDougal LK, Goering RV. et al. Characterization of a strain of community-associated methicillin-resistant Staphylococcus aureus widely disseminated in the United States. J Clin Microbiol 2006; 44: 108-118.
5. Naimi TS, LeDell KH, Como-Sabetti KM. et al. Comparison of community and health care associated methicillin-resistant Staphylococcus aureus infection. JAMA 2003; 290: 2976-2984.
6. Frank AL, Marcinak JF, Mangat D, et al. Community acquired and clindamycin susceptible methicillin resistant Staphylococcus aureus in children. Pediatr Infect Dis J 1999; 18: 993-1000.
7. Gillet Y, Issartel B, Vanhems P, et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 2002; 359: 753-759.
8. Gonzalez BE, Martinez-Aguilar G, Hulten KG, et al. Severe Staphylococcal sepsis in adolescents in the era of community acquired methicillin-resistant Staphylococcus aureus. Pediatrics 2005; 115: 642-648.
9. Creech CB 2, Kernodle DS, Alsentzer A, et al. Increasing rates of nasal carriage of methicillin-resistant Staphylococcus aureus in healthy children. Pediatr Infect Dis J 2005; 24: 617-621.
10. Miles AA, Williams REO, Clayton-Cooper B. The carriage of S. aureus in man and its relation to wound infection. J Pathol Bacteriol 1944; 56: 513-524.
11. von Eiff C, Becker K, Machka K, et al. Nasal carriage as a source of Staphylococcus aureus bacteremia. N Engl J Med 2001; 344: 11-16.
12. Srinivasan A, Seifried S, Zhu L, et al. Panton-Valentine Leukocidin positive methicillin-resistant Staphylococcus aureus infections in children with cancer. Pediatr Blood Cancer 2009; 53: 1216-1220.
13. Clinical Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing M100-S18. Vol. 28. No 1, January 2008.
14. Jarraud S, Mougel J, Thioulouse G, et al. Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (alleles) and human disease. Infect Immun 2002; 70: 631-641.
15. Harmsen D, Clause H, Witte W, et al. Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. J Clin Microbiol 2003; 41: 5442-5448.
16. Aires-de-Sousa M, Boye K, de Lencastre H, et al. High interlaboratory reproducibility of DNA sequence-based typing of bacteria in a multicenter study. J Clin Microbiol 2006; 44: 619-621.
17. Hallin M, Deplano A, Denis O, et al. Validation of pulsed-field gel electrophoresis and spa typing for long-term, nationwide epidemiological surveillance studies of Staphylococcus aureus infections. J Clin Microbiol 2007; 45: 127-133.
18. Nakamura MM, Rohling KL, Shashaty M, et al. Prevalence of methicillin-resistant Staphylococcus aureus nasal carriage in the community pediatric population. Pediatr Infect Dis J 2002; 21: 917-922.
19. Kuehnert MJ, Kruszon-Moran D, Hill HA, et al. Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001-2002. J Infect Dis 2006; 193: 172-179.
20. Gorwitz RJ, Kruszon-Moran D, McAllister SK, et al. Changes in the prevalence of Staphylococcus aureus nasal colonization in the United States, 2001-2004. J Infect Dis 2008; 197: 1226-1234.
21. Lo WT, Lin WJ, Tseng MH, et al. Risk factors and molecular analysis of panton-valentine-leukocidin positive methicillin-resistant Staphylococcus aureus colonization in healthy children. Pediatr Infect Dis J 2008; 27: 713-718.
22. Eveillard M, de Lassence A, Larcien E, et al. Evaluation of a strategy of screening multiple anatomical sites for methicillin-resistant Staphylococcus aureus at Admission to a Teaching Hospital. Infect Control Hosp Epidemiol 2006; 27: 181-184.
23. Squier C, Rihs JD, Risa KJ, et al. Staphylococcus aureus rectal carriage and its association with infections in patients in a surgical intensive care unit and a liver transplant unit. Infect Control Hosp Epidemiol 2002; 23: 495-501.
24. Srinivasan A, Seifried S, Zhu L, et al. Staphylococcus aureus bacteremia in pediatric patients with cancer. Pediatric Infect Dis J 2009; 29: 172-174.
25. Labandiera-Rey M, Couzon F, Boisset S, et al. Staphylococcus aureus Panton-Valentine Leukocidin causes necrotizing pneumonia. Science 2007; 315: 1130-1137.
26. Wardenburg JB, Palazzolo-Balance AM, Otto M, et al. Panton-Valentine Leukocidin is not a virulence determinant in murine models of community-associated methicillin-resistant Staphylococcus aureus disease. J Infect Dis 2008; 198: 1166-1170.
27. Ellis MW, Hospenthal DR, Dooley DP, et al. Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers. Clin Infect Dis 2004; 39: 971-979.
28. Huang SS, Platt R. Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization. Clin Infect Dis 2003: 281-285.
29. Diep BA, Chambers HF, Graber CJ, et al. Emergence of multidrug-resistant, community-associated methicillin-resistant Staphylococcus aureus Clone USA 300 in men who have sex with men. Ann Intern Med 2008; 148: 249-257.
30. Mest DR, Wong DH, Shimoda KJ, et al. Nasal colonization with methicillin-resistant Staphylococcus aureus on admission to the surgical intensive care unit increases the risk of infection. Anesth Analg 1994; 78: 644-650.
31. Ammerlaan HSM, Kluytmans JAJW, Wertheim HFL, et al. Eradication of methicillin-resistant Staphylococcus aureus carriage: A systematic review. Clin Infect Dis 2009; 48: 922-930.
32. Bode LGM, Kluytmans JAJW, Wertheim HFL, et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med 2010; 362: 9-17.
33. Wertheim HF, Vos MC, Ott A, et al. Mupirocin prophylaxis against nosocomial Staphylococcus aureus infections in nonsurgical patients: A randomized study. Ann Intern Med 2004; 140: 419-425.
34. Morris PG, Hassan T, McNamara M, et al. Emergence of MRSA in positive blood cultures from patients with febrile neutropenia-A cause for concern. Support Care Cancer 2008; 16: 1085-1088.
35. Gopal AK, Fowler VG, Jr., Shah M, et al. Prospective analysis of Staphylococcus aureus bacteremia in nonneutropenic adults with malignancy. J Clin Oncol 2000; 18: 1110-1115.
36. Chemaly RF, Hachem RY, Husni RN, et al. Characteristics and outcomes of methicillin-resistant staphylococcus aureus surgical-site infections in patients with cancer: A case-controlled study. Ann Surg Oncol 2010; 17: 1499-1506.
37. Miyake M, Ohbayashi Y, Iwasaki A, et al. Risk factors for methicillin-resistant Staphylococcus aureus (MRSA) and use of a nasal mupirocin ointment in oral cancer inpatients. J Oral Maxillofac Sur 2007; 65: 2159-2163.
38. Watters K, O'dwyer TP, Rowley H. Cost and morbidity of MRSA in head and neck cancer patients: What are the consequences? J Laryngol Otol 2004; 118: 694-699.